1月28日，赣锋锂业发布业绩预告显示： 锂业龙头企业赣锋锂业预计2025年实现净利润11亿元至16.5亿元，同比扭亏为盈，但扣除非经常性损益后仍将亏损3亿元至6亿元，公司主营业务仍面临 压力。 此外，公司通过转让控股子公司深圳易储数智能源集团有限公司部分股权并成功引入战略投资人，确认了相应的投资收益。 风险提示及免责条款 市场有风险，投资需谨慎。本文不构成个人投资建议，也未考虑到个别用户特殊的投资目标、财务状况或需要。用户应考虑本文中的任何意见、观点或结论是否符合其特定状况。据此投资，责任自负。 归属于上市公司股东的净利润：本报告期预计盈利 11.0 亿元至 16.5 亿元。去年同期为亏损 20.74 亿元，较上年同期增长 153.04% 至 179.56%。 扣除非经常性损益后的净利润：本报告期预计仍处于亏损状态，金额为 3.0 亿元至 6.0 亿元。去年同期亏损 8.87 亿元。 基本每股收益：本报告期预计盈利 0.55 元/股至 0.82 元/股。去年同期为亏损 1.03 元/股。 | 项目 | 本报告期 | 上年同期 | | --- | --- | --- | | 归属上市公司股 | 盈利:110,0 ...

格隆汇1月27日丨赣锋锂业(002460.SZ)公布，预计2025年归属上市公司股东的净利润110,000万元– 165,000万元，同比扭亏为盈，扣非亏损60,000万元–30,000万元。1、报告期内，公司持有的 Pilbara Minerals Limited（PLS）股票价格上涨产生了公允价值变动收益，在领式期权相关的既定风险管理策略 对冲后，整体公允价值变动收益约10.3 亿元。 2、根据《企业会计准则第 22 号》规定，公司将报告期内在H股发行的可转换公司债券整体指定为"以 公允价值计量且其变动计入当期损益的金融负债"。受公司股价显著上涨及绝大部分债券持有人行使转 股权影响，本期确认了相应的公允价值变动损失。3、公司通过转让控股子公司深圳易储数智能源集团 有限公司部分股权并成功引入战略投资人，确认了相应的投资收益。4、根据《企业会计准则第 8 号》 的相关规定，公司对存在减值迹象的资产（包括长期资产）进行了减值测试，并相应计提了资产减值准 备。 ...

南财智讯1月27日电，赣锋锂业发布年度业绩预告，预计2025年全年归属于上市公司股东的净利润为 110000万元—165000万元，同比预增153.04%—179.56%；预计2025年全年归属于上市公司股东的扣除 非经常性损益的净利润为亏损60000万元—30000万元，同比预减亏32.38%—66.19%。业绩变动原因： 1、报告期内，公司持有的PilbaraMineralsLimited（PLS）股票价格上涨产生了公允价值变动收益，在领 式期权相关的既定风险管理策略对冲后，整体公允价值变动收益约10.3亿元。2、根据《企业会计准则 第22号》规定，公司将报告期内在H股发行的可转换公司债券整体指定为"以公允价值计量且其变动计 入当期损益的金融负债"。受公司股价显著上涨及绝大部分债券持有人行使转股权影响，本期确认了相 应的公允价值变动损失。3、公司通过转让控股子公司深圳易储数智能源集团有限公司部分股权并成功 引入战略投资人，确认了相应的投资收益。4、根据《企业会计准则第8号》的相关规定，公司对存在减 值迹象的资产（包括长期资产）进行了减值测试，并相应计提了资产减值准备。上述事项1-3导致的公 允价值变动及投 ...

本报讯 （记者吴文婧）1月20日，百大集团股份有限公司（以下简称"百大集团"）发布2025年年度业绩 预告。公告显示，公司预计2025年度实现归母净利润约700万元，同比减少1.26亿元，降幅达94.73%。 同时，公司预计2025年度实现营业收入约2亿元，同比小幅增长2.87%；扣除非经常性损益后的净利润 约为7500万元，同比下降4.83%。整体来看，在主营业务相对平稳的情况下，百大集团2025年归母净利 润"大跳水"主要是由于非经常性损益的大幅波动。 从具体原因看，公允价值变动成为拖累业绩的核心因素。公告显示，2024年度，百大集团确认公允价值 变动收益约2356.84万元，而2025年度公司确认公允价值变动收益约-1.37亿元，同比减少归母净利润约 1.35亿元。 其中，一方面，百大集团依据杭州工商信托股份有限公司提供的未经审计年报数据，确认相关公允价值 变动收益约-9440万元；另一方面，公司所持二级市场股票因股价下跌，确认公允价值变动收益约-6160 万元，对公司当期利润形成了显著冲击。 （文章来源：证券日报） ...

Core Viewpoint - The company, Zhejiang Zhongma Transmission Co., Ltd., anticipates a significant loss for the fiscal year 2025, primarily due to the bankruptcy restructuring of a major client and related asset impairments [2][4]. Group 1: Performance Forecast - The company expects a net profit attributable to shareholders of between -8 million and -5.4 million yuan for 2025 [2][4]. - The forecasted net profit, excluding non-recurring gains and losses, is projected to be between 14 million and 21 million yuan [5]. Group 2: Previous Year Performance - In the previous year, the company reported a total profit of 35.08 million yuan, with a net profit attributable to shareholders of 33.25 million yuan [6]. - The earnings per share for the previous year were 0.11 yuan [6]. Group 3: Reasons for Expected Loss - The primary reason for the expected loss is the bankruptcy restructuring of Chengdu Dayun Automobile Group Co., Ltd., which has led to a high probability of uncollectible receivables. The company has made an additional provision for bad debts of 3.65 million yuan, with a 100% provision rate [6][12]. - The company has also recognized an asset impairment loss of 13.48 million yuan due to indications of impairment in certain production lines for automatic transmission [6][15]. - Additionally, the company has recorded a fair value loss of 29.51 million yuan on its investment in Chengdu Yingming Zhitong Technology Co., Ltd., due to a decline in the fair value of the equity held [6][16].

Core Viewpoint - The company expects to achieve a net profit attributable to shareholders of the parent company between 1.4 billion to 1.43 billion yuan for the year 2025, representing a year-on-year increase of 366.51% to 376.51% [1] Group 1: Financial Performance - The significant increase in net profit is primarily attributed to substantial growth in non-recurring gains, mainly from the fair value changes of investments in Moer Technology and Muxi Integrated Circuit [1] - The company directly holds 1.3404 million shares of Moer Technology, accounting for 0.29% of its total share capital post-IPO, and indirectly holds 670,100 shares through Qichuang Kexin, representing 0.14% of the total share capital [1] - The company also directly holds 854,300 shares of Muxi Integrated Circuit, which is 0.21% of its total share capital post-IPO [1] Group 2: Investment Strategy - The company classifies its direct holdings in Moer Technology and Muxi Integrated Circuit as "financial instruments measured at fair value with changes recognized in profit or loss," reported under "other non-current financial assets" [1] - The indirect investment in Moer Technology, through the shares held in Qichuang Kexin, is reported as a long-term equity investment [1]

Core Viewpoint - The announcement from Litong Electronics indicates a significant change in the valuation of its investment in Fulade, with a notable loss in the fair value of financial assets impacting the company's profits for the fourth quarter of 2025 [1] Financial Performance - As of December 31, 2025, Litong Electronics confirmed a loss of 22.447 million yuan due to changes in the fair value of other non-current financial assets, which is expected to reduce the profit for Q4 2025 by the same amount [1] - For the entire year of 2025, the company reported a cumulative fair value change gain of 62.71 million yuan, which is anticipated to increase the annual profit by the same amount [1] Stock Performance - The stock price of Fulade decreased from 42.78 yuan per share on September 30, 2025, to 35.80 yuan per share by December 31, 2025, reflecting a decline in market valuation [1]

Core Viewpoint - The company holds equity in Chery New Energy, which was packaged by Chery Automobile for listing on the Hong Kong Stock Exchange at the end of September. Although it has not been listed separately, its value has significantly changed. The company did not find any fair value change for this equity holding in the third quarter [1] Group 1 - The company stated that according to relevant enterprise accounting standards, the equity in Chery New Energy is accounted for under "other equity instrument investments" [1] - If there is a change in the fair value of Chery New Energy, it will be recorded in other comprehensive income and will not affect the company's profit and loss [1] - Investors are advised to refer to the company's periodic reports for specific financial data [1]

Core Viewpoint - The stock of Zhaoyan New Drug (603127) has increased by over 5%, currently trading at 22.38 HKD with a transaction volume of 116 million HKD, indicating a positive market response to recent developments in the preclinical CRO sector [1] Group 1: Market Demand and Supply Dynamics - There is a recovery in demand from preclinical CRO clients, while the supply of experimental monkeys is tight, leading to increased prices [1] - The price of the food crab monkey, essential for safety evaluation tests in drug development, has risen to 140,000 RMB per monkey, reflecting a supply-demand imbalance [1] Group 2: Impact on Drug Development - New technology platforms such as large molecules (multi-antibodies, ADC), small nucleic acids, peptides, and cell gene therapies require food crab monkeys for safety evaluation, highlighting the importance of this resource in innovative drug development [1] - The increase in monkey prices will directly contribute to profit through fair value changes, supporting the recovery of domestic innovative drug research and development [1] Group 3: Financial Projections - According to estimates from Founder Securities, if the average price of experimental monkeys is accounted for at 84,900 RMB in 2024 and increases to 140,000 RMB by Q4 2025, the estimated new fair value addition for Zhaoyan New Drug in 2025 could be approximately 220 million RMB, based on a known population of 23,200 monkeys [1]

Core Insights - The core viewpoint of the articles is that Xunlei's third-quarter financial performance exceeded expectations, driven by significant revenue growth across its main business segments and a substantial gain from its investment in Yingstone Innovation [1][2]. Financial Performance - Xunlei reported total revenue of $126.4 million for the third quarter, representing a year-over-year increase of 57.7% [1]. - Gross profit for the quarter was $60.5 million, with a gross margin of 47.9%, down from 50.5% in the same period last year, indicating a decline of 5.1% [1]. - The increase in gross profit was attributed to higher margins from online advertising, overseas voice live streaming, and membership services [1]. - The net profit based on GAAP was $550.1 million, a significant increase from $4.4 million in the same quarter last year [1]. - Non-GAAP net profit for the quarter was $5.3 million, compared to $4.9 million in the previous year [1]. Earnings Per Share - The diluted earnings per ADS under GAAP were approximately $8.60, compared to $0.07 in the same quarter last year [2]. - The diluted earnings per ADS under non-GAAP were approximately $0.09, slightly up from $0.08 in the previous year [2]. Strategic Insights - The CEO of Xunlei, Li Jinbo, highlighted that the investment in Yingstone Innovation was a major factor contributing to the quarterly profit, with an unrealized gain of approximately $545.8 million from this investment [2]. - The company anticipates that this investment will provide strategic advantages for exploring new expansion, research opportunities, and potential industry collaborations [2].